Thus, we could infer that the RIP1/RIP3/MLKL pathway contributes to glutamate-induced NLRP3 inflammasome activation, and it may be one of the upstream regulators of NLRP3 inflammasome activation in glaucoma. Here, MLKL is linked to glaucoma.